KBC Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.9M | Sell |
35,414
-2,510
| -7% | -$520K | 0.01% | 443 |
|
|
2026
Q1 | $8.51M | Sell |
37,924
-199,680
| -84% | -$49.8M | 0.02% | 373 |
|
|
2025
Q4 | $57.2M | Buy |
237,604
+132,868
| +127% | +$34M | 0.13% | 140 |
|
|
2025
Q3 | $28.7M | Buy |
104,736
+55,612
| +113% | +$15.2M | 0.07% | 221 |
|
|
2025
Q2 | $12.7M | Buy |
49,124
+2,006
| +4% | +$479K | 0.03% | 321 |
|
|
2025
Q1 | $10.5M | Sell |
47,118
-27,135
| -37% | -$6.33M | 0.03% | 346 |
|
|
2024
Q4 | $17M | Buy |
74,253
+1,522
| +2% | +$366K | 0.05% | 298 |
|
|
2024
Q3 | $17.8M | Buy |
72,731
+52,259
| +255% | +$11.7M | 0.05% | 284 |
|
|
2024
Q2 | $3.92M | Sell |
20,472
-5,495
| -21% | -$1.11M | 0.01% | 470 |
|
|
2024
Q1 | $5.14M | Buy |
25,967
+841
| +3% | +$154K | 0.02% | 441 |
|
|
2023
Q4 | $4.32M | Sell |
25,126
-35,168
| -58% | -$5.4M | 0.02% | 489 |
|
|
2023
Q3 | $8.92M | Sell |
60,294
-151,957
| -72% | -$27.5M | 0.04% | 363 |
|
|
2023
Q2 | $46.4M | Buy |
212,251
+115,850
| +120% | +$25.8M | 0.19% | 113 |
|
|
2023
Q1 | $21.1M | Buy |
96,401
+59,389
| +160% | +$12.9M | 0.09% | 219 |
|
|
2022
Q4 | $7.7M | Sell |
37,012
-12,395
| -25% | -$2.72M | 0.04% | 355 |
|
|
2022
Q3 | $10.8M | Sell |
49,407
-3,291
| -6% | -$749K | 0.06% | 282 |
|
|
2022
Q2 | $11M | Buy |
52,698
+1,366
| +3% | +$291K | 0.06% | 286 |
|
|
2022
Q1 | $12.4M | Sell |
51,332
-34,523
| -40% | -$8.35M | 0.05% | 300 |
|
|
2021
Q4 | $22.4M | Sell |
85,855
-61,874
| -42% | -$16.1M | 0.07% | 245 |
|
|
2021
Q3 | $38.9M | Sell |
147,729
-17,807
| -11% | -$4.87M | 0.14% | 172 |
|
|
2021
Q2 | $40.8M | Buy |
165,536
+4,397
| +3% | +$924K | 0.15% | 165 |
|
|
2021
Q1 | $31.3M | Buy |
161,139
+6,135
| +4% | +$1.23M | 0.13% | 193 |
|
|
2020
Q4 | $32.9M | Sell |
155,004
-8,135
| -5% | -$1.62M | 0.15% | 164 |
|
|
2020
Q3 | $28M | Sell |
163,139
-20,855
| -11% | -$3.85M | 0.16% | 142 |
|
|
2020
Q2 | $35.3M | Buy |
183,994
+51,758
| +39% | +$8.47M | 0.23% | 103 |
|
|
2020
Q1 | $19.5M | Buy |
132,236
+28,065
| +27% | +$4.47M | 0.16% | 149 |
|
|
2019
Q4 | $16.1M | Sell |
104,171
-22,702
| -18% | -$3.27M | 0.1% | 235 |
|
|
2019
Q3 | $17.1M | Buy |
126,873
+81,797
| +181% | +$10.7M | 0.13% | 197 |
|
|
2019
Q2 | $5.5M | Buy |
45,076
+503
| +1% | +$55.7K | 0.04% | 416 |
|
|
2019
Q1 | $4.63M | Sell |
44,573
-601
| -1% | -$62K | 0.04% | 431 |
|
|
2018
Q4 | $5.14M | Buy |
45,174
+2,130
| +5% | +$228K | 0.06% | 335 |
|
|
2018
Q3 | $4.96M | Buy |
43,044
+19,494
| +83% | +$2.14M | 0.04% | 437 |
|
|
2018
Q2 | $2.44M | Buy |
23,550
+1,048
| +5% | +$106K | 0.02% | 566 |
|
|
2018
Q1 | $2.21M | Sell |
22,502
-455
| -2% | -$43K | 0.02% | 554 |
|
|
2017
Q4 | $1.94M | Sell |
22,957
-9,776
| -30% | -$808K | 0.02% | 607 |
|
|
2017
Q3 | $2.52M | Buy |
32,733
+5,521
| +20% | +$422K | 0.02% | 550 |
|
|
2017
Q2 | $2.12M | Buy |
27,212
+1,993
| +8% | +$143K | 0.02% | 574 |
|
|
2017
Q1 | $1.81M | Sell |
25,219
-1,075
| -4% | -$74.3K | 0.02% | 677 |
|
|
2016
Q4 | $1.63M | Sell |
26,294
-8,610
| -25% | -$527K | 0.02% | 693 |
|
|
2016
Q3 | $2.26M | Sell |
34,904
-7,108
| -17% | -$473K | 0.03% | 545 |
|
|
2016
Q2 | $2.66M | Sell |
42,012
-920
| -2% | -$54.2K | 0.04% | 464 |
|
|
2016
Q1 | $2.48M | Sell |
42,932
-972
| -2% | -$55K | 0.04% | 442 |
|
|
2015
Q4 | $2.36M | Buy |
43,904
+11,795
| +37% | +$665K | 0.04% | 437 |
|
|
2015
Q3 | $1.64M | Sell |
32,109
-1,276
| -4% | -$68.7K | 0.03% | 488 |
|
|
2015
Q2 | $1.88M | Buy |
33,385
+19,357
| +138% | +$1.22M | 0.02% | 571 |
|
|
2015
Q1 | $1.01M | Buy |
14,028
+1,629
| +13% | +$106K | 0.01% | 730 |
|
|
2014
Q4 | $695K | Buy |
12,399
+4,318
| +53% | +$225K | 0.01% | 860 |
|
|
2014
Q3 | $398K | Sell |
8,081
-5,601
| -41% | -$285K | 0.01% | 804 |
|
|
2014
Q2 | $693K | Sell |
13,682
-14,660
| -52% | -$727K | 0.01% | 837 |
|
|
2014
Q1 | $1.27M | Hold |
28,342
| – | – | 0.02% | 603 |
|
|
2013
Q4 | $1.33M | Sell |
28,342
-907
| -3% | -$45.9K | 0.02% | 607 |
|
|
2013
Q3 | $1.54M | Buy |
29,249
+13,742
| +89% | +$667K | 0.02% | 576 |
|
|
2013
Q2 | $700K | Buy |
+15,507
| New | +$736K | 0.01% | 750 |
|
Other funds holding RMD
KBC Group's RMD Position: Q2 2026 in Review
KBC Group reduced its ResMed (RMD) stake by 6.6% in Q2 2026, selling an estimated $520K and leaving 35,414 shares worth $6.9M. The position accounts for 0.01% of the portfolio, ranked #443.
KBC Group first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $57.2M in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- KBC Group held 35,414 shares of ResMed worth $6.9M as of Q2 2026.
- KBC Group sold 2,510 ResMed shares in Q2 2026, an estimated $520K.
- ResMed made up 0.01% of KBC Group's portfolio in Q2 2026, its #443 holding.
- KBC Group first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- KBC Group's ResMed position peaked at $57.2M in Q4 2025.
- 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.